Physician profile
Daniel R Dziadosz
NPI 1609015452
$261,643.76
in general payments reported to CMS, 2019-2025
21 companies · $5,236 in 2025
The $5,236 reported for 2025 was more than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $2,005 · 2021: $4,976 · 2022: $85K · 2023: $51K · 2024: $78K · 2025: $5,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $98K · Consulting Fee: $20K · Travel and Lodging: $7,944 · Food and Beverage: $5,264 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Long Term Medical Supply Or Device Loan: $932 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $98,006.25 |
| Consulting Fee | $19,662.50 |
| Travel and Lodging | $7,944.30 |
| Food and Beverage | $5,264.29 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Long Term Medical Supply Or Device Loan | $932.37 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $180,889.27 | 2019-2025 | Evos, Evos Mini, Trigen Intertan |
| Zimmer Biomet Holdings, INC. | $41,074.32 | 2019-2025 | Taperloc |
| Globus Medical, INC. | $24,015.13 | 2022-2024 | Proximal Ulna, Ankle Fracture System, Distal Femur Plate System |
| Synthes Gmbh | $7,580.44 | 2019-2025 | |
| Synthes USA Products LLC | $2,824.13 | 2021 | |
| Depuy Synthes Sales INC. | $2,729.15 | 2020-2025 | Na, Motoband, Lcp |
| Integra Lifesciences Corporation | $1,107.53 | 2020-2025 | Integra Dermal Regeneration Template, Integra, Primatrix |
| Stryker Corporation | $503.89 | 2020-2022 | |
| Medical Device Business Services, INC. | $359.28 | 2021 | |
| Kerecis Limited | $252.89 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Electronic Waveform Lab, INC. | $54.92 | 2019 | |
| Avita Medical Americas, LLC | $37.29 | 2025 | Permeaderm, Cohealyx, Recell |
| Nuvasive, INC. | $37.02 | 2022 | |
| Merz North America, INC. | $28.66 | 2023 | Xeomin |
| Kci USA, INC. | $26.81 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $26.41 | 2024 | Airseal |
| Acell, INC. | $23.48 | 2019 | |
| Dynasplint Systems INC. | $21.22 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| My01 INC. | $19.47 | 2025 | My01 Continuous Compartmental Pressure Monitor |
| Orthofix Medical, INC. | $12.45 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Dziadosz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.